Articles

The latest news for pharma industry insiders.

Pharma Pulse 3/8/24: Lilly's New Campaign Challenges Misperceptions About Obesity Care,  Challenges Facing Broader Adoption of Novel Cell and Gene Therapies & more

The contributions consist of multiple investments that aim to boost pandemic preparedness and overall public health protection. 

AstraZeneca Intends to Make $831 Million Financial Commitment in the UK

The CDMO’s multi-million-dollar expansion project features commercial manufacturing suites and peptide manufacturing plants.   

Almac Group Grows Northern Ireland HQ, Welcomes New Facilities

Pharma Pulse 3/7/24: Rite Aid Enters into APA, S.E.C. Investigates OpenAI & more

Navigating the complex landscape of healthcare coverage can be an intimidating task, especially for patients with rare diseases for which treatments often come with a high price tag. 

Revolutionizing Rare Disease Treatment: Embracing the Patient-Centric Transformation in Pharmaceutical Customer Engagement

Pharma Pule 3/6/24: Air Pollution Linked to Childhood Asthma, Four-Steps to Accelerate Study Start-up Cycles & more

The CDC urges healthcare providers to preserve their current supply. 

Tetanus Vaccine Now Facing Shortages

The pTau217 antibody helps pinpoint pathological changes related to the disease. 

Alamar Biosciences and ALZpath Announce Collaboration Centered on Furthering Alzheimer’s Disease Research

Pharma Pulse 3/5/24: How the Pandemic Changed the Way Pharma Looks at Data Integrity in 2024, ow Your Protein Needs Change as You Age & more

Momentum from the previous two years will propel the sector into the rest of 2024, says AM Best analysis.

News